REG - Deutsche Bank AG UDG Healthcare Plc - Form 38.5a (EPT/RI) - UDG Healthcare plc

Deutsche Bank AGAnnouncement

10/06/2021 10:50

RNS Number : 4929B
  
Deutsche Bank AG
  
10 June 2021
  
 

Ap24
 
FORM 38.5(a)
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
 
1.       KEY INFORMATION
 




Name of exempt principal trader


 Deutsche Bank AG London




Company dealt in


 UDG Healthcare plc




Class of relevant security to which the dealings being disclosed relate (Note 1)


 Ordinary Shares




Date of dealing


 09/06/2021




 
2.        DEALINGS (Note 2)
 
(a)      Purchases and sales
 




Total number of relevant securities acquired


Highest price paid (Note 3)


Lowest price paid
(Note 3)




 1,429 


10.4800 GBP


10.4800 GBP




 
 




Total number of securities disposed


Highest price received (Note 3)


Lowest price received
(Note 3)




 1,429 


10.4803 GBP


10.4803 GBP




 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 4)


Number of relevant securities
(Note 5)


Price per unit
(Note 3)
EUR




 


 


 


 




 
Ap25
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 5)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 3)




 


 


 


 


 


 


 




 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 3)




 


 


 




 
3.      OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
Full details of any agreement, arrangement or understanding between the person disclosing and 
any other person relating to the voting rights of any relevant securities under any option referred to 
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities 
to which any derivative referred to on this form is referenced. If none, this should be stated.           
                
                None
 
 
 
 




Date of disclosure


10/06/2021




Contact name


Harvinder Bhambra




Telephone number


0121 615 7167




Name of offeree/offeror with which connected


 Nenelite Limited




Nature of connection (Note 6)


 Financial Adviser and Corporate Broker




 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEGCGDLLSBDGBG